Retirement should be a time of exploration, expansion and delight. So if you've done your planning well, enjoy these four ...

Primis Financial (NASDAQ:FRST) said on Tuesday that the regional lender expects an after-tax gain of ~$20.0M, or $0.81 per ...

today reported financial results for the quarter ended March 31, 2025, and provided a corporate update. “The first quarter of 2025 marked yet another exciting milestone for Gain with the first ...

Threat actors motivated by financial gain continue to rise in prominence, representing 55% of all cyber actors during 2024, according to a report by Mandiant. The figures show a steady increase ...

Shares of banks and other financial institutions rose amid hopes for continued calm in global markets. One observer said another bout of volatility is highly possible, given the uncertain situation ...

Shares of banks and other financial institutions rose as a rebound in global equity markets gained steam. By one measure, the S&P 500 was set to re-enter bull market territory, rising by almost 20% ...

Gain Therapeutics reports Q1 2025 financial results, progressing Phase 1b study of Parkinson's treatment GT-02287, with FDA engagement anticipated. Successful administration of GT-02287 ...

Eos has a competitive advantage in manufacturing its systems in America, with 91 per cent of its supply chain U.S.-based ...

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS ...